PanCAN Chief Scientific and Medical Officer Anna Berkenblit discusses how PanCAN supports all patients diagnosed with ...
Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today announced the presentation of Phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback